Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) fell 3.9% on Friday .The company traded as low as $10.46 and last traded at $10.36. 8,771 shares changed hands during mid-day trading ...
WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback